Details for New Drug Application (NDA): 203584
✉ Email this page to a colleague
The generic ingredient in CLARITHROMYCIN is clarithromycin. There are twenty-one drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the clarithromycin profile page.
Summary for 203584
| Tradename: | CLARITHROMYCIN |
| Applicant: | Hec Pharm |
| Ingredient: | clarithromycin |
| Patents: | 0 |
Pharmacology for NDA: 203584
| Mechanism of Action | Cytochrome P450 3A Inhibitors Cytochrome P450 3A4 Inhibitors P-Glycoprotein Inhibitors |
Medical Subject Heading (MeSH) Categories for 203584
Suppliers and Packaging for NDA: 203584
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CLARITHROMYCIN | clarithromycin | TABLET;ORAL | 203584 | ANDA | Lannett Company, Inc. | 0527-1931 | 0527-1931-06 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0527-1931-06) |
| CLARITHROMYCIN | clarithromycin | TABLET;ORAL | 203584 | ANDA | Lannett Company, Inc. | 0527-1932 | 0527-1932-06 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0527-1932-06) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
| Approval Date: | Sep 28, 2015 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
| Approval Date: | Sep 28, 2015 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
